Botteri Philippe
CIK: 0001856713
Associated companies
Transaction History
| PATH | ▲ Buy | Grant | 19,175 | $0 | 6/25/2026 | View on chart |
| PATH | ▲ Buy | Grant | 16,064 | $0 | 6/26/2025 | View on chart |
| PATH | ▲ Buy | Grant | 17,021 | $0 | 6/20/2024 | View on chart |
| PATH | ▼ Sell | Other | 2,922,838 | $0 | 6/15/2023 | View on chart |
| PATH | ▼ Sell | Other | 44,522 | $0 | 6/15/2023 | View on chart |
| PATH | ▼ Sell | Other | 168,010 | $0 | 6/15/2023 | View on chart |
| PATH | ▲ Buy | Grant | 10,995 | $0 | 6/15/2023 | View on chart |
| PATH | ▼ Sell | Other | 9,451 | $0 | 6/15/2023 | View on chart |
| PATH | ▼ Sell | Other | 79,461 | $0 | 6/15/2023 | View on chart |
| PATH | ▼ Sell | Other | 282,404 | $0 | 6/15/2023 | View on chart |
| PATH | ▼ Sell | Other | 1,661,324 | $0 | 6/15/2023 | View on chart |
| PATH | ▼ Sell | Other | 11,318 | $0 | 6/5/2023 | View on chart |
| PATH | ▼ Sell | Other | 95,151 | $0 | 6/5/2023 | View on chart |
| PATH | ▼ Sell | Other | 3,500,000 | $0 | 6/5/2023 | View on chart |
| PATH | ▼ Sell | Other | 53,313 | $0 | 6/5/2023 | View on chart |
| PATH | ▼ Sell | Other | 338,168 | $0 | 6/5/2023 | View on chart |
| PATH | ▼ Sell | Other | 201,299 | $0 | 6/5/2023 | View on chart |
| PATH | ▼ Sell | Other | 1,989,379 | $0 | 6/5/2023 | View on chart |
| PATH | ▼ Sell | Other | 1,989,379 | $0 | 5/31/2023 | View on chart |
| PATH | ▼ Sell | Other | 11,318 | $0 | 5/31/2023 | View on chart |
| PATH | ▼ Sell | Other | 95,151 | $0 | 5/31/2023 | View on chart |
| PATH | ▼ Sell | Other | 3,500,000 | $0 | 5/31/2023 | View on chart |
| PATH | ▼ Sell | Other | 53,313 | $0 | 5/31/2023 | View on chart |
| PATH | ▼ Sell | Other | 338,168 | $0 | 5/31/2023 | View on chart |
| PATH | ▼ Sell | Other | 201,026 | $0 | 5/31/2023 | View on chart |
| PATH | ▲ Buy | Grant | 10,351 | $0 | 6/16/2022 | View on chart |
| PATH | ▼ Sell | Other | 1,661,324 | $0 | 10/8/2021 | View on chart |
| PATH | ▼ Sell | Other | 9,451 | $0 | 10/8/2021 | View on chart |
| PATH | ▼ Sell | Other | 79,461 | $0 | 10/8/2021 | View on chart |
| PATH | ▼ Sell | Other | 2,922,838 | $0 | 10/8/2021 | View on chart |
| PATH | ▼ Sell | Other | 44,522 | $0 | 10/8/2021 | View on chart |
| PATH | ▼ Sell | Other | 282,404 | $0 | 10/8/2021 | View on chart |
| PATH | ▼ Sell | Other | 166,055 | $0 | 10/8/2021 | View on chart |
| PATH | ▼ Sell | Other | 1,661,324 | $0 | 10/5/2021 | View on chart |
| PATH | ▼ Sell | Other | 9,451 | $0 | 10/5/2021 | View on chart |
| PATH | ▼ Sell | Other | 79,461 | $0 | 10/5/2021 | View on chart |
| PATH | ▼ Sell | Other | 2,922,838 | $0 | 10/5/2021 | View on chart |
| PATH | ▼ Sell | Other | 44,522 | $0 | 10/5/2021 | View on chart |
| PATH | ▼ Sell | Other | 282,404 | $0 | 10/5/2021 | View on chart |
| PATH | ▼ Sell | Other | 166,054 | $0 | 10/5/2021 | View on chart |
| PATH | ▼ Sell | Other | 9,451 | $0 | 9/27/2021 | View on chart |
| PATH | ▼ Sell | Other | 79,461 | $0 | 9/27/2021 | View on chart |
| PATH | ▼ Sell | Other | 2,922,838 | $0 | 9/27/2021 | View on chart |
| PATH | ▼ Sell | Other | 44,522 | $0 | 9/27/2021 | View on chart |
| PATH | ▼ Sell | Other | 166,112 | $0 | 9/27/2021 | View on chart |
| PATH | ▼ Sell | Other | 1,661,324 | $0 | 9/27/2021 | View on chart |
| PATH | ▼ Sell | Other | 282,404 | $0 | 9/27/2021 | View on chart |
| PATH | ▼ Sell | Other | 1,661,324 | $0 | 9/21/2021 | View on chart |
| PATH | ▼ Sell | Other | 9,451 | $0 | 9/21/2021 | View on chart |
| PATH | ▼ Sell | Other | 79,461 | $0 | 9/21/2021 | View on chart |
| PATH | ▼ Sell | Other | 2,922,838 | $0 | 9/21/2021 | View on chart |
| PATH | ▼ Sell | Other | 44,522 | $0 | 9/21/2021 | View on chart |
| PATH | ▼ Sell | Other | 282,404 | $0 | 9/21/2021 | View on chart |
| PATH | ▼ Sell | Other | 166,093 | $0 | 9/21/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
UiPath Downgraded After Investor Day, Despite New Oracle Partnership
UiPath received a downgrade from analysts following its recent investor day, where the presentation failed to impress. This negative reaction contrasts with recent positive news, including a new test cloud availability on the Oracle Marketplace and recognition as a leader in adaptive process orchestration. The stock is currently trading near its 52-week low, reflecting the market's cautious stance despite these operational updates.
UiPath Downgraded After Investor Day, Despite New Oracle Partnership. UiPath received a downgrade from analysts following its recent investor day, where the presentation failed to impress. This negative reaction contrasts with recent positive news, including a new test cloud availability on the Oracle Marketplace and recognition as a leader in adaptive process orchestration. The stock is currently trading near its 52-week low, reflecting the market's cautious stance despite these operational updates.